The authors recommended screening for CLCN5 and/or OCRL mutations in all males presenting with LMWP irrespective of any additional clinical features (nephrolithiasis or nephrocalcinosis, hypercalciuria, rickets, or CKD). This evidence concerns the gene CLCN5 and nephrolithiasis.